Itopride Pellets

Itopride PelletsItopride (INN) is a prokinetic benzamide derivative unlike metoclopramide or domperidone.

These drugs inhibit dopamine and have a gastrokinetic effect.

Itopride is indicated for the treatment of functional dyspepsia and other gastrointestinal conditions.

Itopride is not currently approved by the U.S. Food and Drug Administration (FDA) for use in the United States, nor is it yet approved in the United Kingdom.

Availble Form:
Itopride HCL SR Pellets
Itopride Hydrochloride
Itopride Granules

Umang Pharmatech equipments used for production of Itopride Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Itopride Pellets
Systematic (IUPAC) Name
Itopride Pellets
Identifiers
Itopride Pellets
Chemical data
N-[[4-(2-Dimethylaminoethoxy)phenyl]methyl]-3,4-dimethoxybenzamide
CAS number : 122898-67-3
ATC code : None
PubChem : CID 3792
UNII : 81BMQ80QRL
KEGG : D08094
Formula : C20H26N2O4
Mol. mass : 358.43 g/mol


* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech
TESTIMONIAL